GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » Market Cap

Shanghai Kehua Bio-engineering Co (SZSE:002022) Market Cap : ¥3,513 Mil (As of May. 26, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Shanghai Kehua Bio-engineering Co's share price for the quarter that ended in Mar. 2024 was ¥7.97. Shanghai Kehua Bio-engineering Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 514 Mil. Therefore, Shanghai Kehua Bio-engineering Co's market cap for the quarter that ended in Mar. 2024 was ¥4,099 Mil.

Shanghai Kehua Bio-engineering Co's quarterly market cap increased from Sep. 2023 (¥4,629 Mil) to Dec. 2023 (¥5,853 Mil) but then declined from Dec. 2023 (¥5,853 Mil) to Mar. 2024 (¥4,099 Mil).

Shanghai Kehua Bio-engineering Co's annual market cap declined from Dec. 2021 (¥7,632 Mil) to Dec. 2022 (¥6,362 Mil) and declined from Dec. 2022 (¥6,362 Mil) to Dec. 2023 (¥5,853 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shanghai Kehua Bio-engineering Co's Enterprise Value for Today is ¥2,720 Mil.


Shanghai Kehua Bio-engineering Co Market Cap Historical Data

The historical data trend for Shanghai Kehua Bio-engineering Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kehua Bio-engineering Co Market Cap Chart

Shanghai Kehua Bio-engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,009.68 7,931.38 7,631.97 6,361.85 5,852.76

Shanghai Kehua Bio-engineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,685.86 5,451.56 4,628.68 5,852.76 4,099.11

Competitive Comparison of Shanghai Kehua Bio-engineering Co's Market Cap

For the Medical Devices subindustry, Shanghai Kehua Bio-engineering Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Kehua Bio-engineering Co's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai Kehua Bio-engineering Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Shanghai Kehua Bio-engineering Co's Market Cap falls into.



Shanghai Kehua Bio-engineering Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Shanghai Kehua Bio-engineering Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥11.38*514.302
=¥5,853

Shanghai Kehua Bio-engineering Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥7.97*514.317
=¥4,099

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Kehua Bio-engineering Co  (SZSE:002022) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Shanghai Kehua Bio-engineering Co Market Cap Related Terms

Thank you for viewing the detailed overview of Shanghai Kehua Bio-engineering Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Kehua Bio-engineering Co (SZSE:002022) Business Description

Traded in Other Exchanges
N/A
Address
No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
Executives
Li Ming Executives
He Jian Wen Executives
Ji Yu Ming Supervisors
Li Ji Executives
Sha Li Wu Director
Wang Man Directors, executives
Tang Wei Guo Director

Shanghai Kehua Bio-engineering Co (SZSE:002022) Headlines

No Headlines